Saved in:
Bibliographic Details
Main Authors: Luu, Phuong Vu, Nguyen, Cuong-Quoc, Ton-Nu, Huong Lien, Phan, Thuy-Tien Thi, Huynh, Quoc-Dung Tran, Pham, Ngoc-Thac, Le, Huong-Giang, Chen, Lo-Yun, Chang, Yu-Chia, Su, Jui-Hsin, Peng, Bo-Rong, Lai, Kuei-Hung
Format: Artículo científico
Language:en
Published: Bioorganic chemistry 2026
Subjects:
Online Access:https://pubmed.ncbi.nlm.nih.gov/41740353/
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868266082199928833
author Luu, Phuong Vu
Nguyen, Cuong-Quoc
Ton-Nu, Huong Lien
Phan, Thuy-Tien Thi
Huynh, Quoc-Dung Tran
Pham, Ngoc-Thac
Le, Huong-Giang
Chen, Lo-Yun
Chang, Yu-Chia
Su, Jui-Hsin
Peng, Bo-Rong
Lai, Kuei-Hung
author_facet Luu, Phuong Vu
Nguyen, Cuong-Quoc
Ton-Nu, Huong Lien
Phan, Thuy-Tien Thi
Huynh, Quoc-Dung Tran
Pham, Ngoc-Thac
Le, Huong-Giang
Chen, Lo-Yun
Chang, Yu-Chia
Su, Jui-Hsin
Peng, Bo-Rong
Lai, Kuei-Hung
Luu, Phuong Vu
Nguyen, Cuong-Quoc
Ton-Nu, Huong Lien
Phan, Thuy-Tien Thi
Huynh, Quoc-Dung Tran
Pham, Ngoc-Thac
Le, Huong-Giang
Chen, Lo-Yun
Chang, Yu-Chia
Su, Jui-Hsin
Peng, Bo-Rong
Lai, Kuei-Hung
collection PubMed - marine biology
contents Stereoselective AChE/BChE/BACE1 inhibition by enantiomeric norsesquiterpenoids with an unprecedented oxatricyclo[7.2.1.0]dodecane scaffold from the soft coral Sclerophytum humesi. Luu, Phuong Vu Nguyen, Cuong-Quoc Ton-Nu, Huong Lien Phan, Thuy-Tien Thi Huynh, Quoc-Dung Tran Pham, Ngoc-Thac Le, Huong-Giang Chen, Lo-Yun Chang, Yu-Chia Su, Jui-Hsin Peng, Bo-Rong Lai, Kuei-Hung Animals Cholinesterase Inhibitors Acetylcholinesterase Stereoisomerism Structure-Activity Relationship Anthozoa Molecular Structure Sesquiterpenes Butyrylcholinesterase Humans Dose-Response Relationship, Drug Molecular Docking Simulation Chemical investigation of the soft coral Sclerophytum humesi led to the discovery of (±)-norsclerohumin A (1), a pair of enantiomeric norsesquiterpenoids possessing an unprecedented oxatricyclo[7.2.1.0]dodecane scaffold with a rare C5-O-C8 intramolecular ether-bridge. Their structures were elucidated by comprehensive spectroscopic analysis, including NMR, HRESIMS, ECD, and DP4+ analysis. A plausible biosynthetic pathway is proposed to account for the formation of the unique ether-bridged oxatricyclic framework and the generation of the enantiomeric pair (±)-norsclerohumin A. In addition, the absolute configuration of sinunorcaryophyllenol (2) was fully determined for the first time. Mechanistic studies revealed pronounced stereoselective inhibition of acetylcholinesterase (AChE), in which (-)-1b was far more potent than its antipode (+)-1a, with IC values of 10.08 ± 0.48 μM and 149.8 ± 1.02 μM, respectively. Enzyme kinetics showed that (-)-1b is a mixed-type AChE inhibitor (K = 6.61 μM), binding both the free enzyme and enzyme-substrate complex. Molecular docking indicated that its ether-bridged oxatricyclic skeleton fits optimally in the AChE active site, stabilizing key interactions within both the catalytic and peripheral binding regions. Importantly, (-)-1b displayed selective AChE inhibition without detectable cytotoxicity toward normal cells (IC > 256 μM), underscoring its favorable safety profile. Furthermore, pharmacokinetic predictions and quantum chemical parameters further suggest favorable drug-like properties, including high gastrointestinal absorption, blood-brain barrier permeability, and low risk of P-glycoprotein/cytochrome P450 interactions. These findings highlight the oxatricyclo[7.2.1.0dodecane scaffold as a promising lead for neurotherapeutic development.
format Artículo científico
id pubmed_41740353
institution PubMed
language en
publishDate 2026
publisher Bioorganic chemistry
record_format pubmed
spellingShingle Stereoselective AChE/BChE/BACE1 inhibition by enantiomeric norsesquiterpenoids with an unprecedented oxatricyclo[7.2.1.0]dodecane scaffold from the soft coral Sclerophytum humesi.
Luu, Phuong Vu
Nguyen, Cuong-Quoc
Ton-Nu, Huong Lien
Phan, Thuy-Tien Thi
Huynh, Quoc-Dung Tran
Pham, Ngoc-Thac
Le, Huong-Giang
Chen, Lo-Yun
Chang, Yu-Chia
Su, Jui-Hsin
Peng, Bo-Rong
Lai, Kuei-Hung
Animals
Cholinesterase Inhibitors
Acetylcholinesterase
Stereoisomerism
Structure-Activity Relationship
Anthozoa
Molecular Structure
Sesquiterpenes
Butyrylcholinesterase
Humans
Dose-Response Relationship, Drug
Molecular Docking Simulation
Stereoselective AChE/BChE/BACE1 inhibition by enantiomeric norsesquiterpenoids with an unprecedented oxatricyclo[7.2.1.0]dodecane scaffold from the soft coral Sclerophytum humesi. Luu, Phuong Vu Nguyen, Cuong-Quoc Ton-Nu, Huong Lien Phan, Thuy-Tien Thi Huynh, Quoc-Dung Tran Pham, Ngoc-Thac Le, Huong-Giang Chen, Lo-Yun Chang, Yu-Chia Su, Jui-Hsin Peng, Bo-Rong Lai, Kuei-Hung Animals Cholinesterase Inhibitors Acetylcholinesterase Stereoisomerism Structure-Activity Relationship Anthozoa Molecular Structure Sesquiterpenes Butyrylcholinesterase Humans Dose-Response Relationship, Drug Molecular Docking Simulation Chemical investigation of the soft coral Sclerophytum humesi led to the discovery of (±)-norsclerohumin A (1), a pair of enantiomeric norsesquiterpenoids possessing an unprecedented oxatricyclo[7.2.1.0]dodecane scaffold with a rare C5-O-C8 intramolecular ether-bridge. Their structures were elucidated by comprehensive spectroscopic analysis, including NMR, HRESIMS, ECD, and DP4+ analysis. A plausible biosynthetic pathway is proposed to account for the formation of the unique ether-bridged oxatricyclic framework and the generation of the enantiomeric pair (±)-norsclerohumin A. In addition, the absolute configuration of sinunorcaryophyllenol (2) was fully determined for the first time. Mechanistic studies revealed pronounced stereoselective inhibition of acetylcholinesterase (AChE), in which (-)-1b was far more potent than its antipode (+)-1a, with IC values of 10.08 ± 0.48 μM and 149.8 ± 1.02 μM, respectively. Enzyme kinetics showed that (-)-1b is a mixed-type AChE inhibitor (K = 6.61 μM), binding both the free enzyme and enzyme-substrate complex. Molecular docking indicated that its ether-bridged oxatricyclic skeleton fits optimally in the AChE active site, stabilizing key interactions within both the catalytic and peripheral binding regions. Importantly, (-)-1b displayed selective AChE inhibition without detectable cytotoxicity toward normal cells (IC > 256 μM), underscoring its favorable safety profile. Furthermore, pharmacokinetic predictions and quantum chemical parameters further suggest favorable drug-like properties, including high gastrointestinal absorption, blood-brain barrier permeability, and low risk of P-glycoprotein/cytochrome P450 interactions. These findings highlight the oxatricyclo[7.2.1.0dodecane scaffold as a promising lead for neurotherapeutic development.
title Stereoselective AChE/BChE/BACE1 inhibition by enantiomeric norsesquiterpenoids with an unprecedented oxatricyclo[7.2.1.0]dodecane scaffold from the soft coral Sclerophytum humesi.
topic Animals
Cholinesterase Inhibitors
Acetylcholinesterase
Stereoisomerism
Structure-Activity Relationship
Anthozoa
Molecular Structure
Sesquiterpenes
Butyrylcholinesterase
Humans
Dose-Response Relationship, Drug
Molecular Docking Simulation
url https://pubmed.ncbi.nlm.nih.gov/41740353/